Boston Clinical Trials   Report issue

For profit Phase 1 Phase 2
Founded: Boston MA United States (2003)

Organization Overview

First Clinical Trial
2013
NCT01874951
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Boston Clinical Trials | Boston Clinical Trials (BCT)

Active Ingredients

Drugs in Phase 2 Trials (1)

naltrexone (revia) (1 trial)

Drugs in Phase 1 Trials (1)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Depression (Phase 2)

Depressive Disorder (Phase 2)

Depressive Disorder, Major (Phase 2)

Recurrence (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2